Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Freeport-McMoRan Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $361.59 (market cap $9.55B), while Freeport-McMoRan Inc trades at $66.82 (market cap $96.91B). The key difference: Freeport-McMoRan Inc is far larger — about 10.1× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Freeport-McMoRan Inc pays a 0.87% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | FCX | |
|---|---|---|
Market Cap | $9.55B | $96.91B |
Sector | Health | Basic Materials |
52-Week High | $362.08 | $71.73 |
52-Week Low | $241.71 | $35.34 |
Enterprise Value | $9.31B | $103.19B |
Dividend Yield | — | 0.87% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
